期刊文献+

经尿道膀胱肿瘤电切联合吡柔比星灌注治疗浅表性膀胱癌疗效观察 被引量:16

Efficacy of Transurethral Resection of Bladder Tumor Combined with Pirarubicin Perfusion
下载PDF
导出
摘要 [目的]探讨经尿道等离子膀胱肿瘤电切术(TURBT) 联合吡柔比星灌注治疗浅表性膀胱癌的安全性与有效性.[方法]用经尿道等离子体双极电切系统膀胱肿瘤电切(transurethral resection of the bladder tumor,TURBT)治疗膀胱癌90例,肿瘤分级G1为72例,G2为18例.电极切除肿瘤直达深肌层,同时扩大到电切距肿瘤基底1 cm范围的正常组织,术后定期进行膀胱内灌注吡柔比星化疗.[结果]手术时间5~46 min,平均(14±12) min.术中无经尿道电切综合征,发生闭孔神经反射11例,其中腹膜外穿孔1例.随访3~24 个月,8例复发,7例再行TURBT,1例并发尿道移形上皮癌,并行全尿道切除术,术后追踪观察至今未复发.[结论]TURBT联合吡柔比星膀胱灌注是治疗浅表性膀胱癌是的一种理想方法,疗效好,创伤小,副反应低,值得推广应用. [Objective]To explore the safety and effectiveness of transurethral resection of bladder tumor (TURBT) combined with pirarubicin perfusion for the treatment of superficial bladder cancer. [Methods] Totally 90 cases of bladder cancer including 72 cases with grade G1 and 18 cases with grade (32 were treated with TURBT by using transurethral bipolar plasma system. Electrode resection reached to the deep muscle layer and extended to normal tissues at lcm around tumor basement. After operation, all patients were given regular bladder perfusion chemotherapy with pirarubicin. [Results]The operation time ranged from 5 to 46min with a mean of (14± 12)min. No intraoperative transurethral resection syndrome occurred. Obturator nerve reflex occurred in 11 cases including one case of extraperitoneal perforation. All patients were followed up for 3-24 months. Eight cases relapsed in which 7 cases underwent TURBT again and one case complicated with urethral transitional epithelial cancer underwent total ureth- rectomy. During the follow up to now, none of these 8 cases recurred. [Conclusion] TURBT combined with piraru- bicin bladder perfusion for the treatment of superficial bladder cancer is an ideal method with good efficacy, small trauma.and low side effects, so it is worthy of clinical promotion.
作者 石通 梁蔚波
出处 《医学临床研究》 CAS 2012年第4期638-640,共3页 Journal of Clinical Research
关键词 膀胱肿瘤/外科学 电外科手术 尿道/外科学 阿霉素/治疗应用 Bladder neoplasms/SU electrosurgery urethra/SU doxorubicin/TU
  • 相关文献

参考文献8

  • 1Rodriguez J, Chechile G, Algaba F, et al . Value of random endoscopic biopsy in the diagnosis of bladder carcinoma in situ [J]. Fur Urol , 1987, 13 (2) : 150 -154.
  • 2陈梓甫.表浅膀胱癌的诊断与治疗[J].临床泌尿外科杂志,2003,18(5):257-258. 被引量:88
  • 3那彦群.经尿道膀胱肿瘤切除术[M].见:郭应禄.腔内泌尿外科学.第2版.北京:人民军医出版社,1995:97-104.
  • 4熊永新,伍洋.经尿道膀胱肿瘤切除术86例[J].现代医药卫生,2008,24(21):3223-3224. 被引量:1
  • 5Metts MC. Bladder cancer: a review of diagnosis and manage- ment[J]. JNatlMedAssoc ,2000, 92(6) : 285- 294.
  • 6TOMA C, JOHN MF. Bladder Canner. In: Robert JS, Mike BS, John MF. Clinical Urology [M]. Philadephia: JB LiDDincott Compang , 1994:637 644.
  • 7Brausi M, Collette L, Kurth K. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies[J]. Eur Urol ,2002, 41(2): 523- 531.
  • 8叶敏,舒畅,马邦一,陈建华,张良.吡柔比星诱导膀胱癌细胞凋亡的实验研究及预防膀胱癌术后复发的效果[J].中华泌尿外科杂志,2002,23(1):16-18. 被引量:157

二级参考文献4

共引文献245

同被引文献119

  • 1蒋建光,沈周俊.吡柔比星膀胱内灌注防治浅表性膀胱癌术后复发[J].中国医院药学杂志,2007,27(8):1117-1118. 被引量:12
  • 2Katumalla FS, Devasia A, Kumar R, et al. Second transurethral resection in T1 G3 bladder tumors - Selectively avoidable. Indian J Urol, 2011 ,27(2) :176 - 179.
  • 3Gaya JM, Palou J, Cosentino M, et al. A second transurethral re- section could be not necessary in all high grade non - muscle - in- vasive bladder tumors. Actas Urol Esp ,2012 ,36 (9) :539 -544.
  • 4Kim W, Song C, Park S, et al. Value of immediate second resec- tion of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor. J Endourol, 2012,26 ( 8 ) : 1059 - 1064.
  • 5葛波,杨燕伟,张天禹,高漓.吡柔比星联合白细胞介素Ⅱ膀胱灌注防治浅表性膀胱癌复发的研究[J].临床和实验医学杂志,2007,6(12):53-54. 被引量:10
  • 6Naselli A,Introini C,Bertolotto F,et al. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethralresection of newly diagnosed non-muscle-invasive high-grade bladdercancer[ J]. BJU international,2010,105(2) :208-211.
  • 7Babjuk M,Oosterlinck W,Sylvester R,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update[J] . Actas Urol6gicas Espafiolas ( English Edition),2012,36 ( 7 ):389402.
  • 8Tilki D,Burger M,Dalbagni G,et al. Urine markers for detection andsurveillance of non-muscle-invasive bladder cancer[ J]. European urol-ogy,2011,60(3) :484-492.
  • 9Gkritsios P, Hatzimouratidis K,Kazantzidis S, et al. Hexaminolevuli-nate-guided transurethral resection of non-muscle-invasive bladdercancer does not reduce the recurrence rates after a 2-year follow-up : aprospective randomized trial [ J ] . International urology and nephrolo-gy,2014,46(5) :927-933.
  • 10Kausch I, Sommerauer M, Montorsi F, et al. Photodynamic diagnosisin non-muscle-invasive bladder cancer: a systematic review and cu-mulative analysis of prospective studies[ J]. European urology ,2010,57(4);595-606.

引证文献16

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部